vs
Side-by-side financial comparison of Frontdoor, Inc. (FTDR) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Frontdoor, Inc. is the larger business by last-quarter revenue ($451.0M vs $397.6M, roughly 1.1× Guardian Pharmacy Services, Inc.). Frontdoor, Inc. runs the higher net margin — 9.1% vs 5.3%, a 3.8% gap on every dollar of revenue.
Frontdoor, Inc. operates a leading U.S.-focused home services and protection platform. It offers customizable home warranty plans covering repairs and replacements for household appliances, HVAC, plumbing, and electrical systems, plus on-demand access to a network of pre-vetted local service professionals for residential maintenance and repairs.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
FTDR vs GRDN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $451.0M | $397.6M |
| Net Profit | $41.0M | $20.9M |
| Gross Margin | 55.0% | 21.5% |
| Operating Margin | — | 7.7% |
| Net Margin | 9.1% | 5.3% |
| Revenue YoY | 5.9% | — |
| Net Profit YoY | 10.8% | — |
| EPS (diluted) | $0.57 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $451.0M | — | ||
| Q4 25 | $432.0M | $397.6M | ||
| Q3 25 | $618.0M | $377.4M | ||
| Q2 25 | $617.0M | $344.3M | ||
| Q1 25 | $426.0M | $329.3M | ||
| Q4 24 | $383.0M | — | ||
| Q3 24 | $540.0M | $314.4M | ||
| Q2 24 | $542.0M | — |
| Q1 26 | $41.0M | — | ||
| Q4 25 | $1.0M | $20.9M | ||
| Q3 25 | $106.0M | $9.8M | ||
| Q2 25 | $111.0M | $9.0M | ||
| Q1 25 | $37.0M | $9.4M | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $100.0M | $-122.0M | ||
| Q2 24 | $92.0M | — |
| Q1 26 | 55.0% | — | ||
| Q4 25 | 49.3% | 21.5% | ||
| Q3 25 | 57.1% | 19.8% | ||
| Q2 25 | 57.7% | 19.8% | ||
| Q1 25 | 55.2% | 19.5% | ||
| Q4 24 | 48.0% | — | ||
| Q3 24 | 56.7% | 19.4% | ||
| Q2 24 | 56.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 7.7% | ||
| Q3 25 | 23.0% | 4.3% | ||
| Q2 25 | 23.7% | 3.7% | ||
| Q1 25 | 11.3% | 3.9% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 24.8% | -33.3% | ||
| Q2 24 | 22.9% | — |
| Q1 26 | 9.1% | — | ||
| Q4 25 | 0.2% | 5.3% | ||
| Q3 25 | 17.2% | 2.6% | ||
| Q2 25 | 18.0% | 2.6% | ||
| Q1 25 | 8.7% | 2.9% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 18.5% | -38.8% | ||
| Q2 24 | 17.0% | — |
| Q1 26 | $0.57 | — | ||
| Q4 25 | $0.03 | — | ||
| Q3 25 | $1.42 | — | ||
| Q2 25 | $1.48 | — | ||
| Q1 25 | $0.49 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $1.30 | — | ||
| Q2 24 | $1.18 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $603.0M | $65.6M |
| Total DebtLower is stronger | $1.2B | $0 |
| Stockholders' EquityBook value | $230.0M | $217.9M |
| Total Assets | $2.2B | $412.7M |
| Debt / EquityLower = less leverage | 5.07× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $603.0M | — | ||
| Q4 25 | $566.0M | $65.6M | ||
| Q3 25 | $563.0M | $36.5M | ||
| Q2 25 | $562.0M | $18.8M | ||
| Q1 25 | $506.0M | $14.0M | ||
| Q4 24 | $436.0M | — | ||
| Q3 24 | $375.0M | $37.2M | ||
| Q2 24 | $419.0M | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.1B | $0 | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $565.0M | $34.3M | ||
| Q2 24 | $569.0M | — |
| Q1 26 | $230.0M | — | ||
| Q4 25 | $242.0M | $217.9M | ||
| Q3 25 | $316.0M | $195.5M | ||
| Q2 25 | $254.0M | $179.7M | ||
| Q1 25 | $198.0M | $163.2M | ||
| Q4 24 | $239.0M | — | ||
| Q3 24 | $261.0M | $133.9M | ||
| Q2 24 | $214.0M | — |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.1B | $412.7M | ||
| Q3 25 | $2.2B | $390.0M | ||
| Q2 25 | $2.2B | $356.3M | ||
| Q1 25 | $2.1B | $334.0M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $1.2B | $348.0M | ||
| Q2 24 | $1.2B | — |
| Q1 26 | 5.07× | — | ||
| Q4 25 | 4.73× | 0.00× | ||
| Q3 25 | 3.64× | — | ||
| Q2 25 | 4.56× | — | ||
| Q1 25 | 5.88× | — | ||
| Q4 24 | 4.90× | — | ||
| Q3 24 | 2.16× | 0.26× | ||
| Q2 24 | 2.66× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $34.6M |
| Free Cash FlowOCF − Capex | $114.0M | — |
| FCF MarginFCF / Revenue | 25.3% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $387.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $101.0M | $34.6M | ||
| Q3 25 | $64.0M | $28.2M | ||
| Q2 25 | $127.0M | $19.9M | ||
| Q1 25 | $124.0M | $17.6M | ||
| Q4 24 | $58.0M | — | ||
| Q3 24 | $25.0M | — | ||
| Q2 24 | $103.0M | — |
| Q1 26 | $114.0M | — | ||
| Q4 25 | $95.0M | — | ||
| Q3 25 | $58.0M | $24.2M | ||
| Q2 25 | $120.0M | — | ||
| Q1 25 | $117.0M | — | ||
| Q4 24 | $50.0M | — | ||
| Q3 24 | $16.0M | — | ||
| Q2 24 | $91.0M | — |
| Q1 26 | 25.3% | — | ||
| Q4 25 | 22.0% | — | ||
| Q3 25 | 9.4% | 6.4% | ||
| Q2 25 | 19.4% | — | ||
| Q1 25 | 27.5% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 16.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.0% | 1.1% | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 2.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 101.00× | 1.65× | ||
| Q3 25 | 0.60× | 2.87× | ||
| Q2 25 | 1.14× | 2.21× | ||
| Q1 25 | 3.35× | 1.86× | ||
| Q4 24 | 6.44× | — | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 1.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.